Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by Khaled A. Alswat
Total Records ( 2 ) for Khaled A. Alswat
  Khaled A. Alswat , Reem Waslallah Alsuwat , Kholoud Metaeb Aljaed and Daif Allah M. Almalki
  Background and Objective: Patients with Type II Diabetes (T2D) are at high risk for developing serious diabetes related complications. The primary study goal was to assess the weight stigma among our T2D patients and its relation to various diabetes and cardiovascular related markers. Materials and Methods: A cross-sectional study was carried out for adult T2D patients whom had a routine clinic visit between the period of May-August, 2019. Validated Weight Self Stigma (WSS) Questionnaire was used and those with a total score of >30 points were considered at increased risk of stigmatization. Study included a total of 663 T2D patients with a mean age of 57.3±22.0 years, mostly female with long standing diabetes and a mean BMI in the overweight range. Results: About 45.6% of the sample were considered to have high risk for self-stigmatization. Compared to those whom considered to have low risk for self-stigmatization, those who were high risk were mostly female (p 0.046), have longer T2D duration (p 0.161), higher BMI and higher systolic blood pressure (p<0.001 and 0.006), lower diastolic blood pressure (p 0.004), higher resting heart rate (p 0.002), more likely to be divorced (p 0.046), higher educational level and income (both p<0.001), have retinopathy and neuropathy (p<0.001 and 0.009) and exercise more than 150 min/week if physically active (p<0.001). Conclusion: High risk self-stigmatization was highly prevalent among T2D patients’ sample. It was also associated with worsening in some of the measured cardiovascular markers and having more microvascular complications despite the comparable HbA1c and lipid profiles.
  Khaled A. Alswat
  Background and Objective: Type II Diabetes (T2D) is considered a major health burden locally, regionally and internationally. Gender differences in T2D prevalence were found in several epidemiological and observational studies. The primary goal of this study was to assess the prevalence of T2D-related comorbidities and treatment modalities and the impact of gender. Materials and Methods: This was a cross-sectional study that was conducted between June of 2013 and July of 2016 for patients with T2D at the 2 main outpatient diabetes clinics in Taif city, Saudi Arabia. Those with type I diabetes, gestational diabetes and drug-induced diabetes were excluded. Result: A total of 945 patients with a mean age of 58.4±11.8 years with a nearly equal distribution among both genders but with slightly more male predominance (52.2%). When compared to females, male patients were more likely to be older (p<0.001) and exhibit a longer T2D duration (P 0.003), lower mean BMI (p<0.001), lower systolic blood pressure (P 0.062), higher diastolic blood pressure (P 0.468), less likely to have hypertension and be on ACE/ARB blockers (P 0.065 and 0.019, respectively), more likely to have hyperlipidemia and be on a statin (P 0.065 and 0.124, respectively), and more likely to have cardiac disease and stroke and to be on beta-blockers (P 0.005, 0.279, 0.005, respectively). Conclusion: Both genders exhibited comparable HbA1c levels. Medical treatment optimization along with controlling both measured cardiovascular makers and laboratory result levels was based on comorbidities and complications rather than gender.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility